rs121918426
Variant summary
Our verdict is Benign. Variant got -11 ACMG points: 2P and 13B. PM5BP4_StrongBP6BS1BS2
The ENST00000373106.6(CSF3R):c.1919C>T(p.Thr640Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000227 in 1,614,200 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T640N) has been classified as Pathogenic.
Frequency
Consequence
ENST00000373106.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -11 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CSF3R | NM_000760.4 | c.1919C>T | p.Thr640Ile | missense_variant | 15/17 | ENST00000373106.6 | NP_000751.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CSF3R | ENST00000373106.6 | c.1919C>T | p.Thr640Ile | missense_variant | 15/17 | 1 | NM_000760.4 | ENSP00000362198 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00126 AC: 192AN: 152206Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000414 AC: 104AN: 251194Hom.: 1 AF XY: 0.000309 AC XY: 42AN XY: 135798
GnomAD4 exome AF: 0.000119 AC: 174AN: 1461876Hom.: 2 Cov.: 31 AF XY: 0.0000976 AC XY: 71AN XY: 727236
GnomAD4 genome AF: 0.00126 AC: 192AN: 152324Hom.: 0 Cov.: 33 AF XY: 0.00113 AC XY: 84AN XY: 74484
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:2
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Jun 05, 2017 | The T640I variant in the CSF3R gene has not been reported previously as a germline pathogenic variant, nor as a benign variant, to our knowledge. However, a missense variant at this same codon (T640N) has been reported in one family with autosomal dominant neutrophilia (Plo et al., 1999). The T640I variant is observed in 55/10268 (0.54%) alleles from individuals of African background in the ExAC dataset (Lek et al., 2016). The T640I variant is a non-conservative amino acid substitution, which occurs at a position that is not conserved. In silico analysis predicts this variant likely does not alter the protein structure/function. We interpret T640I as a variant of uncertain significance. - |
Likely benign, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
Likely benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Feb 22, 2017 | - - |
Autosomal recessive severe congenital neutropenia due to CSF3R deficiency Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 22, 2023 | - - |
CSF3R-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 24, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at